International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Excipients and Adverse Events

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2023 - Volume 27, Number 5
View All Articles in Issue

Page(s): 382-385

Download in electronic PDF format for $75

Abstract: Pharmaceutical excipients are substances formulated with an active ingredient in a medication. This article has provided a brief discussion on excipients, the purpose of excipients, the selection of appropriate excipients, the use of excipients in formulation development by compounding pharmacists/manufacturers, excipient examples and usage, the numerous incompatibilities that should be considered when choosing an excipient, and a list of adverse effects related to excipients.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, excipients, incompatibilities, adverse effects, pH effects, chemical instability, physical instability

Related Categories: EXCIPIENTS, STABILITIES, COMPATIBILITIES, ADVERSE DRUG EVENTS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Excipients and Adverse Events Allen Loyd V Jr	Sep/Oct 2023 Pg. 382-385
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Basics of Compounding for Terrorist Attacks, Part 2 Allen Loyd V Jr	Mar/Apr 2003 Pg. 129-134 View Sample
Basics: Excipients Used in Nonsterile Compounding, Part 1 Allen Loyd V Jr	Jul/Aug 2019 Pg. 305-311
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations Allen Loyd V Jr	Sep/Oct 2023 Pg. 397-409
Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories Allen Loyd V Jr	Jan/Feb 2022 Pg. 34-38
Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Zur Eyal	Nov/Dec 2018 Pg. 446-454
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Okeke Claudia C, Allen Loyd V Jr	Jul/Aug 2010 Pg. 328-331
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K	Jan/Feb 2013 Pg. 74-85 View Sample
Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets Azmi Nurual Hanisah Saiful, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai	Jan/Feb 2022 Pg. 80-87
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Zur Eyal	Mar/Apr 2012 Pg. 117-124
Basics of Compounding: Clinical Pharmaceutics, Part 2 Allen Loyd V Jr	Nov/Dec 2016 Pg. 485-493
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Allen Loyd V Jr	Jan/Feb 2020 Pg. 44-50
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases Allen Loyd V Jr	Jul/Aug 2021 Pg. 304-309
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott	May/Jun 2013 Pg. 247-253
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Lebrun John, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M	Mar/Apr 2004 Pg. 156-159
The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet Alhmoud Hassan, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani	Sep/Oct 2023 Pg. 431-439
Excipient Choices for Special Populations Nagel-Edwards Karen M, Ko James Y	Sep/Oct 2008 Pg. 426-430
Basics of Compounding: Clinical Pharmaceutics, Part 1 Allen Loyd V Jr	Sep/Oct 2016 Pg. 389-396
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3 Deleruyelle Laura J	Jan/Feb 2017 Pg. 6-16
Return to Top